Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsung-Lang Chiu

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Oncology Reports|June 10, 2016
Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivoChin-Cheng Su, Tsung-Lang Chiu
International Journal of Molecular Medicine|January 1, 2010
Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potentialTsung-Lang Chiu, Chin-Cheng Su
Molecular Medicine Reports|March 25, 2017
Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1α, CHOP, caspase‑3 and caspase‑12 in pancreatic cancer BxPC‑3 cell‑derived xenograft tumorsTsung-Lang Chiu, Chin Cheng Su
International Journal of Molecular Medicine|March 17, 2009
Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cellsTsung-Lang Chiu, Chin-Cheng Su
British Journal of Neurosurgery|May 8, 2013
Dissecting aneurysm at the A1 segment of the anterior cerebral artery presenting as visual loss and visual field defectSheng-Wen Wu, Tsung-Lang Chiu
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 10, 2012
Prediction of flow augmentation and complications of extracranial-intracranial bypass in symptomatic cerebrovascular diseasesTsung-Lang Chiu, Sheng-Tzung Tsai, Cheng-Hui Chiu
Anti-Cancer Drugs|March 10, 2022
Biodegradable controlled-release polymer containing butylidenephthalide to treat a recurrent cervical spine glioblastoma with promising result: a compassionate trial reportYan-Hong Pan, Shinn-Zong Lin, Tsung-Lang Chiu
International Journal of Molecular Medicine|July 3, 2010
The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastomaChin-Cheng Su, Mei-Jen Wang, Tsung-Lang Chiu
Oncology Reports|March 15, 2011
Enhanced anti-glioblastoma activity of microglia by AAV2-mediated IL-12 through TRAIL and phagocytosis in vitroTsung-Lang Chiu, Chih-Wen Peng, Mei-Jan Wang
Tzu Chi Medical Journal|June 8, 2018
Superficial temporal artery-middle cerebral artery bypass for the treatment of complex middle cerebral artery aneurysmsChien-Hui Lee, Sheng-Tzung Tsai, Tsung-Lang Chiu
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Oncology Reports|June 10, 2016
Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivoChin-Cheng Su, Tsung-Lang Chiu
International Journal of Molecular Medicine|January 1, 2010
Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potentialTsung-Lang Chiu, Chin-Cheng Su
Molecular Medicine Reports|March 25, 2017
Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1α, CHOP, caspase‑3 and caspase‑12 in pancreatic cancer BxPC‑3 cell‑derived xenograft tumorsTsung-Lang Chiu, Chin Cheng Su
International Journal of Molecular Medicine|March 17, 2009
Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cellsTsung-Lang Chiu, Chin-Cheng Su
British Journal of Neurosurgery|May 8, 2013
Dissecting aneurysm at the A1 segment of the anterior cerebral artery presenting as visual loss and visual field defectSheng-Wen Wu, Tsung-Lang Chiu
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 10, 2012
Prediction of flow augmentation and complications of extracranial-intracranial bypass in symptomatic cerebrovascular diseasesTsung-Lang Chiu, Sheng-Tzung Tsai, Cheng-Hui Chiu
Anti-Cancer Drugs|March 10, 2022
Biodegradable controlled-release polymer containing butylidenephthalide to treat a recurrent cervical spine glioblastoma with promising result: a compassionate trial reportYan-Hong Pan, Shinn-Zong Lin, Tsung-Lang Chiu
International Journal of Molecular Medicine|July 3, 2010
The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastomaChin-Cheng Su, Mei-Jen Wang, Tsung-Lang Chiu
Oncology Reports|March 15, 2011
Enhanced anti-glioblastoma activity of microglia by AAV2-mediated IL-12 through TRAIL and phagocytosis in vitroTsung-Lang Chiu, Chih-Wen Peng, Mei-Jan Wang
Tzu Chi Medical Journal|June 8, 2018
Superficial temporal artery-middle cerebral artery bypass for the treatment of complex middle cerebral artery aneurysmsChien-Hui Lee, Sheng-Tzung Tsai, Tsung-Lang Chiu
Pageof 5